483 related articles for article (PubMed ID: 19887781)
21. [Stability of hemoglobin levels: an indispensible paradigm change in medical management].
Zaoui P; Deray G; Ortiz JP; Rostaing L
Nephrol Ther; 2011 Feb; 7(1 Suppl 2):H5-7. PubMed ID: 21371678
[No Abstract] [Full Text] [Related]
22. Resistance to recombinant human erythropoietin treatment in thalassaemic patients on chronic haemodialysis: a real clinical entity?
Tarng DC; Huang TP; Chen TW; Fan CY; Chang JG
Nephrol Dial Transplant; 1996 Sep; 11(9):1893-5. PubMed ID: 8918654
[No Abstract] [Full Text] [Related]
23. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
24. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.
Kuragano T; Shimonaka Y; Kida A; Furuta M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
Am J Nephrol; 2010; 31(6):534-40. PubMed ID: 20484891
[TBL] [Abstract][Full Text] [Related]
25. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M.
Beirão I; Almeida S; Swinkels D; Costa PM; Moreira L; Fonseca I; Freitas C; Cabrita A; Porto G
Blood Cells Mol Dis; 2008; 41(2):175-8. PubMed ID: 18544472
[TBL] [Abstract][Full Text] [Related]
26. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
Swinkels DW; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2450-3. PubMed ID: 18495744
[No Abstract] [Full Text] [Related]
27. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
[No Abstract] [Full Text] [Related]
28. Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients.
Sany D; Elsawy AE; Elshahawy Y
Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):967-73. PubMed ID: 25193892
[TBL] [Abstract][Full Text] [Related]
29. Effects of erythropoietin therapy on iron absorption in chronic renal failure.
Skikne BS; Ahluwalia N; Fergusson B; Chonko A; Cook JD
J Lab Clin Med; 2000 Jun; 135(6):452-8. PubMed ID: 10850644
[TBL] [Abstract][Full Text] [Related]
30. Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease.
Arabul M; Gullulu M; Yilmaz Y; Akdag I; Kahvecioglu S; Eren MA; Dilek K
Clin Biochem; 2008 Sep; 41(13):1055-8. PubMed ID: 18571502
[TBL] [Abstract][Full Text] [Related]
31. [Chronic inflammation, oxidative stress and effects of erythropoetin in end-stage renal disease patients].
Lazarević T; Stojimirović B; Poskurica M; Lazarević M; Mitrović N; Stolić R
Med Pregl; 2007; 60 Suppl 2():109-13. PubMed ID: 18928173
[TBL] [Abstract][Full Text] [Related]
32. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate.
Peters HP; Laarakkers CM; Swinkels DW; Wetzels JF
Nephrol Dial Transplant; 2010 Mar; 25(3):848-53. PubMed ID: 19854845
[TBL] [Abstract][Full Text] [Related]
33. Hepcidin in anemia and inflammation in chronic kidney disease.
Malyszko J; Mysliwiec M
Kidney Blood Press Res; 2007; 30(1):15-30. PubMed ID: 17215586
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin resistance in the treatment of the anemia of chronic renal failure.
Priyadarshi A; Shapiro JI
Semin Dial; 2006; 19(4):273-8. PubMed ID: 16893403
[TBL] [Abstract][Full Text] [Related]
35. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
[No Abstract] [Full Text] [Related]
36. [Transferrin microheterogeneity in patients treated by maintenance haemodialysis].
Formanowicz D; Pietrzak I; Wiktorowicz K
Przegl Lek; 2007; 64(7-8):483-8. PubMed ID: 18409349
[TBL] [Abstract][Full Text] [Related]
37. The treatment of anemia in peritoneal dialysis patients.
Lacson E; Diaz-Buxo JA
Clin Nephrol; 2001 Dec; 56(6):415-27. PubMed ID: 11770793
[TBL] [Abstract][Full Text] [Related]
38. Do hemodialysis patients need higher doses of erythropoietin if given intravenously rather than subcutaneously?
McMahon LP
Nat Clin Pract Nephrol; 2006 May; 2(5):246-7. PubMed ID: 16932434
[No Abstract] [Full Text] [Related]
39. Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause.
Waalen J; von Löhneysen K; Lee P; Xu X; Friedman JS
Eur J Haematol; 2011 Aug; 87(2):107-16. PubMed ID: 21535154
[TBL] [Abstract][Full Text] [Related]
40. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?
Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Mysliwiec M
Am J Nephrol; 2005; 25(6):586-90. PubMed ID: 16254410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
